A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

Overview of attention for article published in Drug Design, Development and Therapy, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 1 Wikipedia article.

Simmerafil (TPN171H) is a selective PDE5 inhibitor in development for the treatment of erectile dysfunction and pulmonary hypertension.